TBCRC 031: Randomized Phase II Study of Neoadjuvant Cisplatin Versus Doxorubicin-Cyclophosphamide in Germline <i>BRCA</i> Carriers With HER2-Negative Breast Cancer (the INFORM trial)
Beth Israel Deaconess Medical Center
Nadine Tung; Banu Arun; Michele R Hacker; Erin Hofstatter; Deborah L Toppmeyer; Steven J Isakoff; Virginia Borges; Robert D Legare; Claudine Isaacs; Antonio C Wolff; Paul Kelly Marcom; Erica L Mayer; Paulina B Lange; Andrew J Goss; Colby Jenkins; Ian E Krop; Eric P Winer; Stuart J Schnitt; Judy E Garber